ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 337

$632K Total Retail Price of All Prescriptions

Rank: 40 out of 337

581 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 684 562 1 2
AMLODIPINE BESYLATE 588 499 2 3
ATENOLOL 474 438 3 10
SIMVASTATIN 445 355 4 1
LEVOTHYROXINE SODIUM 423 381 5 5
ATORVASTATIN CALCIUM 413 363 6 7
HYDROCHLOROTHIAZIDE 398 382 7 9
OMEPRAZOLE 388 332 8 4
METOPROLOL TARTRATE 343 312 9 6
ALENDRONATE SODIUM 334 301 10 19
LOVASTATIN 282 279 11 24
METFORMIN HCL 217 166 12 12
HYDROCODONE-ACETAMINOPHEN 199 139 S3 13 13
ENALAPRIL MALEATE 177 165 14 37
TAMSULOSIN HCL 171 153 15 25
FUROSEMIDE 170 121 16 8
DOXAZOSIN MESYLATE 164 164 17 68
ZOLPIDEM TARTRATE 163 120 18 23
FENOFIBRATE 159 119 19 48
SERTRALINE HCL 151 116 20 18
LOSARTAN POTASSIUM 151 148 20 15
RANITIDINE HCL 148 118 22 30
TRAZODONE HCL 140 84 23 16
METOPROLOL SUCCINATE 134 116 24 21
PRAVASTATIN SODIUM 127 81 25 14
PANTOPRAZOLE SODIUM 124 81 26 36
WARFARIN SODIUM 123 118 27 11
NIASPAN 117 86 28 157
AMLODIPINE BESYLATE-BENAZEPRIL 116 100 29 97
DIOVAN 109 105 30 26
ZETIA 106 61 31 89
NEXIUM 98 81 32 56
BISOPROLOL FUMARATE 98 76 32 67
EVISTA 91 91 34 102
DILTIAZEM 24HR ER 88 88 35 76
GABAPENTIN 86 57 36 20
LIPITOR 85 79 37 33
QUINAPRIL HCL 82 81 38 50
CITALOPRAM HBR 81 35 39 17
TRICOR 78 39 40 134
RAMIPRIL 77 77 41 80
ALPRAZOLAM 76 65 42 78
FELODIPINE ER 75 75 43 79
TRIAMTERENE-HCTZ 69 59 44 39
PAROXETINE HCL 66 23 45 46
GLIPIZIDE 63 62 46 45
TRAMADOL HCL 63 60 46 32
GEMFIBROZIL 63 54 46 114
FINASTERIDE 63 49 46 83
DONEPEZIL HCL 58 58 50 22
PROAIR HFA 57 35 51 38
GLIPIZIDE XL 56 46 52 123
CRESTOR 56 23 52 29
ADVAIR DISKUS 53 23 54 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 39 54 31
SINGULAIR 52 14 56 113
CLOPIDOGREL 51 36 57 42
ALLOPURINOL 51 51 57 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.